Endothelial dysfunction enhances vasoconstriction due to scavenging of nitric oxide by a hemoglobin-based oxygen carrier. - Wikidata - awgldk - TriplyDB

Endothelial dysfunction enhances vasoconstriction due to scavenging of nitric oxide by a hemoglobin-based oxygen carrier.

Endothelial dysfunction enhances vasoconstriction due to scavenging of nitric oxide by a hemoglobin-based oxygen carrier.

http://www.wikidata.org/entity/Q33692944

about

New insights into the role of soluble guanylate cyclase in blood pressure regulation Iron accelerates hemoglobin oxidation increasing mortality in vascular diseased guinea pigs following transfusion of stored blood.Reconstructing sickle cell disease: a data-based analysis of the "hyperhemolysis paradigm" for pulmonary hypertension from the perspective of evidence-based medicine.Angiotensin-converting enzyme inhibitor captopril reverses the adverse cardiovascular effects of polymerized hemoglobin.A novel nanobiotherapeutic poly-[hemoglobin-superoxide dismutase-catalase-carbonic anhydrase] with no cardiac toxicity for the resuscitation of a rat model with 90 minutes of sustained severe hemorrhagic shock with loss of 2/3 blood volume.Pulmonary hypertension in lambs transfused with stored blood is prevented by breathing nitric oxide Genetic modifiers of hypertension in soluble guanylate cyclase α1-deficient mice Oxygen carrying capacity of salvaged blood in patients undergoing off-pump coronary artery bypass grafting surgery: a prospective observational study.Examining and mitigating acellular hemoglobin vasoactivity.Haptoglobin Preserves Vascular Nitric Oxide Signaling during Hemolysis In vivo reduction of cell-free methemoglobin to oxyhemoglobin results in vasoconstriction in canines.Blood substitutes: evolution from noncarrying to oxygen- and gas-carrying fluids.Hemoglobin infusion does not alter murine pulmonary vascular tone Diabetes augments and inhaled nitric oxide prevents the adverse hemodynamic effects of transfusing syngeneic stored blood in mice.Inhaled nitric oxide attenuates the adverse effects of transfusing stored syngeneic erythrocytes in mice with endothelial dysfunction after hemorrhagic shock Systems biology of HBOC-induced vasoconstriction.From artificial red blood cells, oxygen carriers, and oxygen therapeutics to artificial cells, nanomedicine, and beyond.Red blood cell replacement, or nanobiotherapeutics with enhanced red blood cell functions?Current Perspectives on Antihypertensive Probiotics.Lowering of elevated tissue PCO2 in a hemorrhagic shock rat model after reinfusion of a novel nanobiotechnological polyhemoglobin-superoxide dismutase-catalase-carbonic anhydrase that is an oxygen and a carbon dioxide carrier with enhanced antioxida Acute kidney function and morphology following topload administration of recombinant hemoglobin solution.Endothelial dysfunction inhibits the ability of haptoglobin to prevent hemoglobin-induced hypertension.Cardioprotective effect of a hemoglobin-based oxygen carrier on cold ischemia/reperfusion injury.Red blood cell endothelial nitric oxide synthase does not modulate red blood cell storage hemolysis.Basic science offers a challenge for developing hemoglobin based oxygen carriers into therapeutic agents.Normalization of hemoglobin-based oxygen carrier-201 induced vasoconstriction: targeting nitric oxide and endothelin.Towards bedside washing of stored red blood cells: a prototype of a simple apparatus based on microscale sedimentation in normal gravity.The quaternary state of polymerized human hemoglobin regulates oxygenation of breast cancer solid tumors: A theoretical and experimental study.Swine hemoglobin as a potential source of artificial oxygen carriers, hemoglobin-vesicles.Encapsulation of hemoglobin inside liposomes surface conjugated with poly(ethylene glycol) attenuates their reactions with gaseous ligands and regulates nitric oxide dependent vasodilation.Storage of nitroglycerin (NTG) admixed with HBOC-201 for 30 days in polyolefin plastic bags: a pilot study.Glutaraldehyde-polymerized hemoglobin and tempol (PolyHb-tempol) has superoxide dismutase activity that can attenuate oxidative stress on endothelial cells induced by superoxide anion.

P2860

Q27021422-7E0AA288-B89D-4534-9C42-E5AA4829E586 Q33631099-39B64DBA-FD9E-450E-8AC1-8E9C3E42DB2B Q33803027-916F8B80-C7DA-4BFF-AA58-F035C86DD2B6 Q34432025-F5575559-3214-44B6-97D6-4A980A5BF146 Q34720661-1C4610B1-0104-4A20-820E-C5D0055542B1 Q35802303-A6C4E37A-BD61-470D-BEF8-6BF95622A08B Q36005369-7A9E615F-6031-4AFC-9BEE-F58D99C556B8 Q36159522-043A79A8-E06A-43C8-819B-B4B0ACF51A84 Q36801603-25B15631-8457-41B1-A92D-026573B78CE6 Q36916070-2E872F7B-5FBA-4BFF-9FCF-ECFE1C58E27A Q36941158-66B67C4E-C6D7-4D80-826E-820C630CCCC4 Q36990411-7E26EBF9-77D9-4A5A-8DB6-91EC8C48609A Q37150808-BFA44243-6626-411C-8D48-D4E0E3C8B43E Q37224411-FFCB0A09-F17F-40A1-B9CD-13623F37EF96 Q37367699-4FC0A445-49C6-4560-BAD8-E3934D026809 Q37897234-B0C4247D-6AB8-4C24-8CF0-32387929FC5B Q37992678-C0CE6A96-9FA8-49B2-BE22-4A6212A95E25 Q38533820-9901970B-F870-47F2-80EB-29FC0B9D4697 Q39024211-6CED912A-A3AE-4D69-BA62-13F507362085 Q39644917-402D068A-BA79-4138-A979-24A26A6DA8B5 Q40082240-9CD0FF0E-AFE7-42CB-8954-1A491D6C1F7E Q40289747-A81A2F32-3C79-45C8-A0FD-A035D772EE83 Q42498522-FA9B1365-62C4-4898-A4F7-C0DDE1E9196E Q43126885-1C0729C3-BEC9-49D1-BDD2-10FB1929A35F Q43600377-F2852960-0384-42DC-AE19-83CA5F27D32E Q46420266-ECE6BE36-43D0-4D5F-8F51-F3FA9FB054E5 Q47412863-44BB664A-8265-4299-8D26-0AB8B3CCEFCB Q50133464-EDE9260B-0FA7-4ED0-88A7-7A4F30D7EBF8 Q50503283-606746C8-ECE9-459F-A30E-C021EB4AC2C3 Q50513933-81EBF126-BAAC-421A-99EA-AA07C00B7D58 Q50519775-B73ED4B1-8727-4693-9864-EC56B42FEA46 Q50637722-98FD359B-BEA4-40E7-A6FC-9677A0A40163

P2860

Endothelial dysfunction enhances vasoconstriction due to scavenging of nitric oxide by a hemoglobin-based oxygen carrier.

http://www.wikidata.org/entity/Q33692944

description

2010 nî lūn-bûn

@nan

2010 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի մարտին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Endothelial dysfunction enhanc ...... moglobin-based oxygen carrier.

@ast

Endothelial dysfunction enhanc ...... moglobin-based oxygen carrier.

@en

type

label

Endothelial dysfunction enhanc ...... moglobin-based oxygen carrier.

@ast

Endothelial dysfunction enhanc ...... moglobin-based oxygen carrier.

@en

prefLabel

Endothelial dysfunction enhanc ...... moglobin-based oxygen carrier.

@ast

Endothelial dysfunction enhanc ...... moglobin-based oxygen carrier.

@en

P1433

Q33692944-B8753FDD-B858-4697-9863-E1592D5DD8D3

P1476

Q33692944-45B1E799-1C5B-4C02-803A-F584747CEE7A

P2093

Q33692944-027A91A4-AC60-4F38-84A4-2A0404BDBAA4

Q33692944-243CD911-2718-4537-B7D2-5560046917DB

Q33692944-2A9D389B-75CD-4896-B3EC-C36125FA5E08

Q33692944-539E6347-CD3F-48DA-B7D4-B73D4959C083

Q33692944-5954EB6B-B372-46F3-A358-F5CDA6A97F37

Q33692944-67705A35-FAFF-4D05-976C-6C2232EFB135

Q33692944-6FE03E65-E03D-447A-99D7-5CA45B0BB73B

Q33692944-94EA0F5E-5348-494A-B582-5B41AEFF1593

Q33692944-D161EAF7-83FB-4676-92F5-95466825981F

P2860

Q33692944-015B6C3E-7190-4616-ADDA-CB253EDEDA76

Q33692944-08295776-5140-42BA-BEDB-277820563E8D

Q33692944-0C2B473E-DE56-46CC-91FE-997FE60F801E

Q33692944-11C917B8-12DF-4E8A-9E96-3D0735058668

Q33692944-217ADABB-1864-4D63-8AF6-4C06EDBDE54B

Q33692944-24EA7C47-128C-4D3E-9058-2362AA96E134

Q33692944-3EACE78C-3478-4053-953D-396193A54837

Q33692944-4ABA1E9E-5643-4515-BC7A-5AA06EE0BDF4

Q33692944-613C554B-D301-4469-8D49-FA4B5813EE9B

Q33692944-95C745B5-19CC-4F58-BAE6-7C3BC3C11DD4

P304

Q33692944-0F611D3F-8040-4CC4-ABBF-D4EAF236F1E1

P31

Q33692944-D6E2FA86-DAB4-418B-BAEA-056103A24D48

P356

Q33692944-E8C296E7-32CB-41B5-91E8-B3851AB48DF6

P407

Q33692944-115BBB4A-57DB-455F-AB02-9B8E9349A05D

P433

Q33692944-6D59C175-980E-4DE8-8607-5C1FBFC634D8

P478

Q33692944-B14F53E0-96A6-4FEE-92A6-E9EDB10AD737

P577

Q33692944-DEA17F19-9FFA-4648-B46E-811EC2DC0B36

P5875

Q33692944-4C36BBAF-E189-44FB-BF92-622E864B77C6

P698

Q33692944-F66D8032-7AF6-462F-9AC8-478FBDE1AE17

P921

Q33692944-64F8F649-B24E-481B-A5C4-172FBFFBCE80

Q33692944-E5DC971C-8654-4C78-9319-B1730F038E2F

P932

Q33692944-103CE3C9-7780-4919-8A20-9E1F1098F15D

P356

ALN.0B013E3181CD7838

P1433

P1476

Endothelial dysfunction enhanc ...... moglobin-based oxygen carrier.

@en

P2093

Binglan Yu

http://www.w3.org/2001/XMLSchema#string

Chong Lei

http://www.w3.org/2001/XMLSchema#string

Elena M Egorina

http://www.w3.org/2001/XMLSchema#string

Kenneth D Bloch

http://www.w3.org/2001/XMLSchema#string

Mei X Wu

http://www.w3.org/2001/XMLSchema#string

Michael J Raher

http://www.w3.org/2001/XMLSchema#string

Mikhail A Sovershaev

http://www.w3.org/2001/XMLSchema#string

Mohd Shahid

http://www.w3.org/2001/XMLSchema#string

Warren M Zapol

http://www.w3.org/2001/XMLSchema#string

P2860

Cell-free hemoglobin-based blood substitutes and risk of myocardial infarction and death: a meta-analysis

Sildenafil ameliorates effects of inhaled nitric oxide withdrawal

Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease.

The clinical sequelae of intravascular hemolysis and extracellular plasma hemoglobin: a novel mechanism of human disease.

Human polymerized hemoglobin for the treatment of hemorrhagic shock when blood is unavailable: the USA multicenter trial.

Blood substitutes as pharmacotherapies in clinical practice.

A short duration of high-fat diet induces insulin resistance and predisposes to adverse left ventricular remodeling after pressure overload.

Prevention of the pulmonary vasoconstrictor effects of HBOC-201 in awake lambs by continuously breathing nitric oxide.

Elevated epidermal growth factor receptor phosphorylation induces resistance artery dysfunction in diabetic db/db mice.

Enhanced vascular reactivity of small mesenteric arteries from diabetic mice is associated with enhanced oxidative stress and cyclooxygenase products

P304

586-594

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/ALN.0B013E3181CD7838

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

112

http://www.w3.org/2001/XMLSchema#string

P577

2010-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

41548568

http://www.w3.org/2001/XMLSchema#string

P698

20179495

http://www.w3.org/2001/XMLSchema#string

P921

vasoconstriction

P932

2829726

http://www.w3.org/2001/XMLSchema#string